Imper Vera bought CTKB
June 10, 2026 · Form 4 insider transaction
Imper Vera bought 18,261 shares of Cytek Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
18,261
Price
$0.00
Total value
N/A
InsiderImper Vera
RoleDirector
SecurityDirector Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after18,261
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares subject to the option shall vest on the earlier of June 10, 2027 and the date of the Issuer's 2027 annual meeting of stockholders (provided such meeting is held in June 2027).